Amundi Asset Management US’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-144
Closed -$7K 1558
2020
Q3
$7K Hold
144
﹤0.01% 1551
2020
Q2
$6K Buy
+144
New +$4.63K ﹤0.01% 1579
2019
Q3
Sell
-3,048
Closed -$150K 1675
2019
Q2
$150K Hold
3,048
﹤0.01% 1522
2019
Q1
$146K Hold
3,048
﹤0.01% 1494
2018
Q4
$187K Hold
3,048
﹤0.01% 1405
2018
Q3
$251K Buy
3,048
+889
+41% +$70.6K ﹤0.01% 1438
2018
Q2
$169K Buy
2,159
+789
+58% +$61.1K ﹤0.01% 1436
2018
Q1
$101K Sell
1,370
-1,440
-51% -$102K ﹤0.01% 1410
2017
Q4
$192K Buy
+2,810
New +$182K ﹤0.01% 1383
2015
Q3
Sell
-71,921
Closed -$3.39M 627
2015
Q2
$3.39M Sell
71,921
-910,327
-93% -$49.3M 0.01% 498
2015
Q1
$59.1M Buy
982,248
+256,477
+35% +$13.1M 0.21% 122
2014
Q4
$31.7M Sell
725,771
-755,892
-51% -$33.4M 0.12% 201
2014
Q3
$66.7M Buy
1,481,663
+471,656
+47% +$25.1M 0.25% 116
2014
Q2
$74.7M Buy
1,010,007
+204,354
+25% +$16.1M 0.29% 102
2014
Q1
$66.7M Buy
805,653
+736,283
+1,061% +$64.7M 0.25% 113
2013
Q4
$9.59M Sell
69,370
-3,064
-4% -$361K 0.04% 337
2013
Q3
$6.93M Buy
72,434
+16,934
+31% +$1.44M 0.03% 404
2013
Q2
$3.39M Buy
+55,500
New +$3.08M 0.01% 496

Other funds holding NUS

Amundi Asset Management US's NUS Position: Q4 2020 in Review

Amundi Asset Management US sold out of Nu Skin (NUS) in Q4 2020, closing a stake of 144 shares — an estimated $7K sold.

Amundi Asset Management US first reported a position in NUS in Q2 2013 and held it in 18 quarters. The position peaked at $74.7M in Q2 2014. 266 funds tracked by Wall St. Rank hold NUS as of Q4 2020.

  • Amundi Asset Management US reported no remaining Nu Skin position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 144 Nu Skin shares in Q4 2020, an estimated $7K.
  • Amundi Asset Management US first reported a position in Nu Skin in Q2 2013 and held it in 18 quarters.
  • Amundi Asset Management US's Nu Skin position peaked at $74.7M in Q2 2014.
  • 266 funds tracked by Wall St. Rank held Nu Skin as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.